AXA Investment Managers’s Novo Nordisk NVO Stock Holding History

AXA Investment Managers’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.07M	Buy	+55,339	New	+$3.24M	0.01%	682

Other funds holding NVO

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AXA Investment Managers's NVO Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Novo Nordisk (NVO) in Q3 2025: 55,339 shares worth $3.07M. The stake represents 0.01% of the portfolio and ranks #682 among its holdings.

1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

AXA Investment Managers held 55,339 shares of Novo Nordisk worth $3.07M as of Q3 2025.
Novo Nordisk was a new AXA Investment Managers position in Q3 2025.
Novo Nordisk made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #682 holding.
1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.